TRIM33 prevents the exacerbation of allergic asthma by restricting the overactivation of alveolar macrophages
Open Access
- 16 July 2025
- journal article
- Published by Elsevier in Mucosal Immunology
- Vol. 18 (5) , 1159-1170
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2022YFC2505002)
- Ministry of Science and Technology of the People's Republic of China (2022YFC2505001)
- Center for Life Sciences
- Tsinghua University
- National Natural Science Foundation of China (31991174)
- National Natural Science Foundation of China (81801641)
- National Natural Science Foundation of China (82388101)
This publication has 46 references indexed in Scilit:
- The basic immunology of asthmaCell, 2021
- TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammationEBioMedicine, 2019
- Impaired Tumor-Necrosis-Factor-α-driven Dendritic Cell Activation Limits Lipopolysaccharide-Induced Protection from Allergic Inflammation in InfantsImmunity, 2019
- Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate DisseminationCell Host & Microbe, 2018
- IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, RespectivelyImmunity, 2016
- Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionImmunity, 2016
- Interleukin-21-Producing CD4+ T Cells Promote Type 2 Immunity to House Dust MitesImmunity, 2015
- Barrier Epithelial Cells and the Control of Type 2 ImmunityImmunity, 2015
- Asthma and Allergic InflammationCell, 2010
- Biology of Lung Dendritic Cells at the Origin of AsthmaImmunity, 2009